Subsequent studies have found elevated TDP-43 levels (by immunoblotting and quantitative mass spectrometry) in the CSF of ALS patients compared to healthy subject and patients with other neurodegenerative or neuroinflammatory diseases, and higher levels in ALS than in FTD [181,182,183]. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.